CD26+ NFs enhanced tumor cell invasion via MMP-activity and recruited monocytes in a CXCL12-dependent manner, indicating that the CAFs derived from CD26+ NFs have a pro-tumorigenic phenotype. This evidence concerns the gene CXCL12 and neoplasm.